Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Modafinil may be effective in relieving fatigue and improving behavioral changes
such as memory loss in patients who have undergone treatment for primary brain cancer. The
effectiveness of modafinil in relieving fatigue and improving behavioral change is not yet
known.
PURPOSE: This randomized clinical trial is comparing how well two different doses of
modafinil work in treating fatigue and behavioral changes in patients who have undergone
treatment for primary brain cancer.